These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30639462)

  • 21. Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations.
    Ceyhan M; Yildirim I; Kurt N; Uysal G; Dikici B; Ecevit C; Aydogan A; Koc A; Yasa O; Köseoğlu M; Onal K; Hacimustafaoglu M; Celebi S
    J Viral Hepat; 2008 Oct; 15 Suppl 2():69-72. PubMed ID: 18837839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology of hepatitis A before and after the introduction of a universal vaccination programme in Catalonia, Spain.
    Domínguez A; Oviedo M; Carmona G; Jansá JM; Borrás E; Salleras L; Plasència A
    J Viral Hepat; 2008 Oct; 15 Suppl 2():51-6. PubMed ID: 18837835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of the single-dose immunization strategy against hepatitis A in Argentina.
    Vizzotti C; González J; Gentile A; Rearte A; Ramonet M; Cañero-Velasco MC; Pérez Carrega ME; Urueña A; Diosque M
    Pediatr Infect Dis J; 2014 Jan; 33(1):84-8. PubMed ID: 24352191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Analysis on epidemiological and serum effect after vaccination of hepatitis A vaccine (HepA)].
    Li JP; Gao ZX; Zhou J
    Zhongguo Yi Miao He Mian Yi; 2010 Jun; 16(3):238-40. PubMed ID: 20726266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changing Epidemiology of Hepatitis A in China: Evidence From Three National Serological Surveys and the National Notifiable Disease Reporting System.
    Wang F; Sun X; Wang F; Zheng H; Jia Z; Zhang G; Bi S; Miao N; Zhang S; Cui F; Li L; Wang H; Liang X; Rodewald LE; Feng Z; Yin Z; Shen L
    Hepatology; 2021 Apr; 73(4):1251-1260. PubMed ID: 32592242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progress Toward Eliminating Hepatitis A Disease in the United States.
    Murphy TV; Denniston MM; Hill HA; McDonald M; Klevens MR; Elam-Evans LD; Nelson NP; Iskander J; Ward JD
    MMWR Suppl; 2016 Feb; 65(1):29-41. PubMed ID: 26916458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis a in Korea: epidemiological shift and call for vaccine strategy.
    Lee D; Cho YA; Park Y; Hwang JH; Kim JW; Kim NY; Lee DH; Lee W; Jeong SH
    Intervirology; 2008; 51(2):70-4. PubMed ID: 18434743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single-Dose Universal Hepatitis A Immunization in Argentina: Low Viral Circulation and High Persistence of Protective Antibodies Up to 4 Years.
    Vizzotti C; González J; Rearte A; Urueña A; Pérez Carrega M; Calli R; Gentile A; Uboldi A; Ramonet M; Cañero-Velasco M; Diosque M
    J Pediatric Infect Dis Soc; 2015 Dec; 4(4):e62-7. PubMed ID: 26582885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis A outbreaks: the effect of a mass vaccination programme.
    Torner N; Broner S; Martinez A; Godoy P; Batalla J; Dominguez A;
    J Viral Hepat; 2011 Apr; 18(4):e1-4. PubMed ID: 21129127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modeling hepatitis A epidemiological profiles and estimating the pediatric vaccination threshold in the Russian Federation.
    Taratorkin FF; Karlsen AA; Kyuregyan KK; Lopatukhina MA; Khankishiyev F; Manuylov VA; Akimkin VG; Mikhailov MI
    Front Public Health; 2024; 12():1371996. PubMed ID: 38993707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Should Brazilian patients with chronic hepatitis C virus infection be vaccinated against hepatitis A virus?
    Villar LM; de Melo MM; Calado IA; de Almeida AJ; Lampe E; Gaspar AM
    J Gastroenterol Hepatol; 2009 Feb; 24(2):238-42. PubMed ID: 19215334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-dose Universal Hepatitis A Immunization in One-year-old Children in Argentina: High Prevalence of Protective Antibodies up to 9 Years After Vaccination.
    Urueña A; González JE; Rearte A; Pérez Carrega ME; Calli R; Pagani MF; Uboldi A; Vicentín R; Caglio P; Cañero-Velasco MC; Gentile A; Ramonet M; Vizzotti C
    Pediatr Infect Dis J; 2016 Dec; 35(12):1339-1342. PubMed ID: 27636725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent trends in hepatitis A incidence in Brazil.
    De Oliveira TM; Vieira NSG; Sepp TDS; Souto FJD
    J Med Virol; 2020 Aug; 92(8):1343-1349. PubMed ID: 32009240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis A vaccine immune response 22 years after vaccination.
    Mosites E; Gounder P; Snowball M; Morris J; Spradling P; Nelson N; Bulkow L; Bruce M; McMahon B
    J Med Virol; 2018 Aug; 90(8):1418-1422. PubMed ID: 29663458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity of booster vaccination with a virosomal hepatitis A vaccine after primary immunization with an aluminum-adsorbed hepatitis A vaccine.
    Beck BR; Hatz CF; Loutan L; Steffen R
    J Travel Med; 2004; 11(4):201-6. PubMed ID: 15541221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population seroprotection against hepatitis a virus in Israel 18 years after introduction of inactivated vaccine into the routine childhood vaccination schedule.
    Galor I; Perry Markovich M; Wolf D; Haber M; Hartal M; Avramovich E
    Vaccine; 2020 Feb; 38(7):1593-1596. PubMed ID: 31932135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modeling the long-term persistence of hepatitis A antibody after a two-dose vaccination schedule in Argentinean children.
    López EL; Contrini MM; Mistchenko A; Kieffer A; Baggaley RF; Di Tanna GL; Desai K; Rasuli A; Armoni J
    Pediatr Infect Dis J; 2015 Apr; 34(4):417-25. PubMed ID: 25764099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A dynamic model for assessing universal Hepatitis A vaccination in Canada.
    Bauch CT; Rao AS; Pham BZ; Krahn M; Gilca V; Duval B; Chen MH; Tricco AC
    Vaccine; 2007 Feb; 25(10):1719-26. PubMed ID: 17229493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis A outbreaks in the vaccination era in Catalonia, Spain.
    Martínez A; Broner S; Torner N; Godoy P; Batalla J; Alvarez J; Barrabeig I; Camps N; Carmona G; Minguell S; Sala R; Caylà J; Domínguez A
    Hum Vaccin; 2011; 7 Suppl():205-10. PubMed ID: 21285534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of hepatitis A vaccination programs for migrant children on the incidence of hepatitis A in The Netherlands.
    Suijkerbuijk AW; Lindeboom R; van Steenbergen JE; Sonder GJ; Doorduyn Y
    Eur J Public Health; 2009 Jun; 19(3):240-4. PubMed ID: 19174503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.